Activation of Alternative Lengthening of Telomeres (ALT) in Primary Pancreatic Neuroendocrine Tumors Serves as Both a Prognostic Biomarker and Potential Therapeutic Target

被引:0
|
作者
Rizzo, Anthony [1 ]
Brosnan-Cashman, Jacqueline [1 ]
Graham, Mindy [1 ]
Hruban, Ralph [1 ]
Heaphy, Christopher [1 ]
机构
[1] Johns Hopkins Univ, Sch Med, Baltimore, MD USA
关键词
D O I
暂无
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
引用
收藏
页码:353 / 353
页数:1
相关论文
共 46 条
  • [1] The Diagnostic and Prognostic Utility of Incorporating DAXX, ATRX, and Alternative Lengthening of Telomeres (ALT) to the Evaluation of Pancreatic Neuroendocrine Tumors (PanNETs)
    Heaphy, Christopher M.
    Singhi, Aatur D.
    HUMAN PATHOLOGY, 2023, 132 : 1 - 11
  • [2] Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
    Claudio Luchini
    Rita T. Lawlor
    Samantha Bersani
    Caterina Vicentini
    Gaetano Paolino
    Paola Mattiolo
    Antonio Pea
    Sara Cingarlini
    Michele Milella
    Aldo Scarpa
    Current Oncology Reports, 2021, 23
  • [3] Alternative Lengthening of Telomeres (ALT) in Pancreatic Neuroendocrine Tumors: Ready for Prime-Time in Clinical Practice?
    Luchini, Claudio
    Lawlor, Rita T.
    Bersani, Samantha
    Vicentini, Caterina
    Paolino, Gaetano
    Mattiolo, Paola
    Pea, Antonio
    Cingarlini, Sara
    Milella, Michele
    Scarpa, Aldo
    CURRENT ONCOLOGY REPORTS, 2021, 23 (09)
  • [4] Alternative Lengthening of Telomeres (ALT) Predicts Disease Free Survival in Small Well Differentiated Pancreatic Neuroendocrine Tumors
    Memon, Raima
    Pisipati, Sailaja
    Al Diffalha, Sameer
    Hartley, Christopher
    Rose, J. Bart
    Reid, Michelle
    Gleeson, Ferga
    Graham, Rondell
    LABORATORY INVESTIGATION, 2024, 104 (03) : S1846 - S1847
  • [5] Predicting recurrence in pancreatic neuroendocrine tumours: role of ARX and alternative lengthening of telomeres (ALT)
    Neyaz, Azfar
    Crotty, Rory
    Rickelt, Steffen
    Pankaj, Amaya
    Stojanova, Marija
    Michelakos, Theodoros P.
    Sekigami, Yurie
    Kontos, Filippos
    Parrack, Paige H.
    Patil, Deepa T.
    Heaphy, Christopher M.
    Ferrone, Cristina R.
    Deshpande, Vikram
    HISTOPATHOLOGY, 2023, 83 (04) : 546 - 558
  • [6] The diagnostic and prognostic utility of incorporating DAXX, ATRX, and alternative lengthening of telomeres to the evaluation of pancreatic neuroendocrine tumors
    Heaphy, Christopher M.
    Singhi, Aatur D.
    HUMAN PATHOLOGY, 2022, 129 : 11 - 20
  • [7] The Detection of Alternative Lengthening of Telomeres using a Novel Chromogenic in situ Hybridization Assay is a Poor Prognostic Biomarker for Patients with Pancreatic Neuroendocrine Tumors
    Patel, Simmi
    Bell, Phoenix
    Heaphy, Christopher
    Singhi, Aatur
    LABORATORY INVESTIGATION, 2023, 103 (03) : S1524 - S1525
  • [8] CT Radiogenomic Characterization of the Alternative Lengthening of Telomeres Phenotype in Pancreatic Neuroendocrine Tumors
    McGovern, Jonathan M.
    Singhi, Aatur D.
    Borhani, Amir A.
    Furlan, Alessandro
    McGrath, Kevin M.
    Zeh, Herbert J., III
    Bahary, Nathan
    Dasyam, Anil K.
    AMERICAN JOURNAL OF ROENTGENOLOGY, 2018, 211 (05) : 1020 - 1025
  • [9] Alternative Lengthening of Telomeres in Primary Pancreatic Neuroendocrine Tumors Is Associated with Aggressive Clinical Behavior and Poor Survival
    Kim, Joo Young
    Brosnan-Cashman, Jacqueline A.
    An, Soyeon
    Kim, Sung Joo
    Song, Ki-Byung
    Kim, Min-Sun
    Kim, Mi-Ju
    Hwang, Dae Wook
    Meeker, Alan K.
    Yu, Eunsil
    Kim, Song Cheol
    Hruban, Ralph H.
    Heaphy, Christopher M.
    Hong, Seung-Mo
    CLINICAL CANCER RESEARCH, 2017, 23 (06) : 1598 - 1606
  • [10] Alternative Lengthening of Telomeres (ALT) and Telomerase Reverse Transcriptase Promoter Methylation in Recurrent Adult and Primary Pediatric Pituitary Neuroendocrine Tumors
    Alzoubi, Hiba
    Minasi, Simone
    Gianno, Francesca
    Antonelli, Manila
    Belardinilli, Francesca
    Giangaspero, Felice
    Jaffrain-Rea, Marie-Lise
    Buttarelli, Francesca Romana
    ENDOCRINE PATHOLOGY, 2022, 33 (04) : 494 - 505